Hong Kong Ferry (Holdings) Company Limited Overview
Hong Kong Ferry (Holdings) is a century-old Hong Kong conglomerate. It began as the territory's largest franchised ferry operator and has turned into a cash-rich property investor that is affiliated with, and about one-third owned by, the Henderson Land group. Its ferry legacy now consists of the sole licensed dangerous-goods vehicular ferry service (North Point–Kwun Tong), the Hong Kong Shipyard in Tsing Yi, and harbour cruises. Profits mainly come from rent on community podium malls in Tai Kok Tsui, Fanling, Yau Tong and Tsuen Wan, from a youth hostel converted from its "The Symphonie" redevelopment, and from interest on more than HKD 2.2 billion of cash. Since 2022 the company has built a premium healthcare and medical-aesthetics business (AMOUR Aesthetic, Total HealthCare, Alliance Medical Centre), which reached break-even in H1 2026. The company has no debt. Its shares trade at about 0.23× book value and below its net cash per share, which makes it a classic Hong Kong "deep-value, low-turnover" family-affiliated holding company.
The company's own description
The FY2025 results announcement and the H1 2026 interim announcement describe operations in three major segments: (1) property development and investment, (2) ferry, shipyard and related operations, and (3) medical, healthcare and beauty services. Securities investment is a fourth, smaller reportable line. Management says the group has operated ferry services in Hong Kong for more than a century and is currently the only Hong Kong company offering vehicular ferry and dangerous-goods vehicular ferry services. It moved into residential property development in the early 2000s and launched its medical specialist and beauty business in 2022. Management presents the three core segments as complementary, diversifying risk and supporting long-term value (2025 Results Announcement, "Development Strategy and Principal Risks"). Its press releases describe the group as having "transformed itself from a ferry and shipyard focused business into an integrated conglomerate" (Gabriel Lee, General Manager, FY2023 to FY2025 releases).
Reportable segments (as defined in the FY2025 accounts)
Property development: development and sale of properties. There was no external revenue in FY2023 to FY2025. The main exposure is the 50% joint venture in "The Royale" (Tuen Mun), which is equity-accounted, so its profits appear as share of JV profits.
Property investment: rental income from shops, commercial arcades and, from June 2025, the "TN Residence" youth hostel.
Ferry, shipyard and related operations: the dangerous-goods vehicular ferry service, ship repair and maintenance at Hong Kong Shipyard, and sales of goods on cruise vessels (Harbour Cruise – Bauhinia).
Medical, healthcare and beauty services: AMOUR Aesthetic (medical aesthetics), Total HealthCare (pain management and chiropractic centres), physiotherapy, and medical-equipment leasing. The H Zentre specialist centre (Alliance Medical Centre) is held through a joint venture.
Securities investment: dividend, interest and fair-value income from listed securities.
Others (unallocated): bank interest income, management fees, air-conditioning charges and corporate costs.
Revenue model
| Revenue type | Segment | Nature | Approx. FY2025 scale (HKD Mn) |
|---|---|---|---|
| Recurring rental (leases) | Property investment | Contracted lease income plus turnover rent (turnover rent was HKD 2.4M in FY2025) | 193.9 segment external revenue; gross rental about 147 |
| Service fees (transport) | Ferry | Regulated fares set by the Transport Department | Included in 165.8 |
| Service fees (ship repair) | Shipyard | Project and job-based repair and maintenance | Included in 165.8 |
| Product sales | Cruise | Food and beverage, goods on vessels | Included in 165.8 |
| Consumer services | Medical/beauty | Treatment fees and prepaid packages (contract liabilities) | 57.1 |
| Equipment leasing | Medical | Rental of jointly purchased medical devices to hospitals and doctors | — |
| Investment income | Securities / Others | Dividends, bank interest, FVPL gains | Interest income 64.3; dividends 7.0 |
| Property sales | Development | Lumpy unit sales, now mostly through the JV | Nil at group revenue level in FY2025 |
The model is therefore mostly service and rental income, with a substantial financial income layer. There is no subscription or licensing income.
Value-chain position, customers and end-markets
HKF sits in four positions in the value chain. It is a landlord and asset owner for community retail; a regulated monopoly-like transport utility (dangerous goods) whose main customers are oil-product distributors and gas suppliers serving Hong Kong Island, including deliveries of flammable gases to hospitals; a marine services provider (repair and maintenance for local vessel owners); and a B2C premium healthcare provider. Customers include retail tenants (supermarkets, F&B, banks, services), the Tung Wah Group of Hospitals (lessee of TN Residence), fuel logistics operators, local shipowners, tourists and local cruise passengers, and affluent individual patients. Essentially all revenue is earned in Hong Kong.
Independent characterisation
Economically, HKF is a cash box with a property portfolio attached. At 30 June 2026, cash (HKD 2,205M) plus investment properties (HKD 4,549M) made up about 87% of total assets (HKD 7,713M). Operating businesses outside property are small: the ferry and shipyard segment lost money in each of FY2023 to FY2025, and the medical segment only turned profitable in H1 2026. Earnings quality depends heavily on three external variables: HIBOR/deposit rates (interest income fell from HKD 99M in FY2023 to HKD 64M in FY2025), Hong Kong retail rental conditions, and property revaluations. Strategic direction is shaped by the Henderson Land relationship. Henderson-linked directors chair the board, related-company balances run in both directions, and the group's stated purpose has historically included sharing synergies with the Henderson Land group.
Strategy
Stated strategic themes (FY2025 Annual Results and 2026 Interim, paraphrased)
-
Diversified, mutually reinforcing three-pillar model. Property, ferry and shipyard, and medical are run as complementary businesses to spread risk.
-
Defensive community-retail leasing. The focus is podium malls serving residents' daily needs, which management considers less exposed to tourist-pattern shifts and northbound cross-border consumption. The company flexes leasing terms and optimises tenant mix.
-
Opportunistic acquisitions at cyclical lows. Management notes that commercial valuations have fallen sharply, creating long-term value opportunities. It will invest "only when returns are attractive and risks are manageable" (company phrasing, abridged).
-
Cost recovery in the ferry business. The company will keep negotiating fare increases with the government, recognising that EV adoption will structurally erode fuel-truck volumes.
-
Event economy and leisure innovation. Themed cruises, classic vehicular-ferry cruises, pet-friendly cruises and the Pierside Run are aligned with the government's "Mega Event Economy" and yacht-hub policies.
-
Shipyard diversification. The company is assessing a change of use for part of the shipyard land.
-
A premium healthcare ecosystem. The aim is to serve high-end, non-hospital clients on quality rather than price, insulating the business from GBA cross-border price competition and from private hospitals' outpatient discounting. The group will add equipment, recruit doctors and specialists, and partner with institutions.
-
"Putting People First" sustainability goal. Initiatives include the youth hostel partnership with TWGHs and harbourfront public amenities.
Initiatives in the last 24 months
| Date | Initiative | Type | Detail |
|---|---|---|---|
| 2H 2024 | Medical equipment leasing | New business | Co-investment with specialists |
| 12 Mar 2025 | Symphonie whole-block lease MOU | Asset repositioning | 262 units leased to a non-profit at market rent |
| 12 Apr 2025 | Dangerous-goods ferry fare rise | Cost recovery | North Point–Kwun Tong route |
| Jun 2025 | TN Residence opens | Social/commercial | Government youth hostel subsidy scheme |
| 2,025 | North Point East Pier bicycle parking | Community | Partnership with a local bicycle company |
| Aug 2025 | Physiotherapy centre, H Zentre | Healthcare expansion | With a fitness partner |
| Sep 2025 | Ferry fare application | Cost recovery | Submitted to the Transport Department |
| 30 Sep 2025 | Tai Hung Fai acquisition | Acquisition | HKD 260M; shop reconfiguration, LED signage |
| Nov 2025 | Alliance Medical Centre rebrand | Brand | Dual-centre model |
| Jan 2026 | Third Total HealthCare centre | Expansion | Tsuen Wan |
| 2025–2026 | AMOUR floor-area expansion | Capacity | Mira Place |
| Apr 2026 | Symphonie car park opens | Monetisation | Short-term parking leases |
| 27 Jun 2026 | New ferry fares | Cost recovery | Expected to cut H2 2026 losses |
| Jul 2026 | Pet-friendly Bauhinia cruise | Product | Leisure/event economy |
| 2,026 | Pierside Run 2026 | Cross-segment | Combines ferry and healthcare |
| Ongoing | Shipyard partial land-use conversion study | Asset optimisation | Feasibility stage |
Guidance and targets
Management gives no quantitative guidance or medium-term financial targets. Qualitatively, it expects revenue in H2 2026 to come primarily from property rentals and bank interest income. It also expects the ferry loss to narrow after the June 2026 fare rise, and expects the medical business "to become profitable", which it achieved in H1 2026. Cost programmes with targets: none disclosed.
Products & Services
Property investment portfolio
| Asset | Location | Type | Status / KPI | Notes |
|---|---|---|---|---|
| Metro6 (commercial arcade) | Tai Kok Tsui, Kowloon | Podium retail | 100% let at Dec 2024, Dec 2025 and Jun 2026 | Community mall |
| Metro Harbour Plaza | Tai Kok Tsui, Kowloon | Large residential podium mall | Occupancy 93% (Dec 2024), 94% (Dec 2025), 93% (Jun 2026) | Hosts a Total HealthCare centre |
| Shining Heights (arcade) | Tai Kok Tsui, Kowloon | Podium retail | Occupancy 95%, then 81%, then 70% (Dec 2024 to Jun 2026) | Weakest asset, still declining |
| The Spectacle (arcade) | Yau Tong / Kowloon East area (per company naming; exact address not in reviewed filings) | Podium retail | 100%, then 91%, then 91% | — |
| Green Code Plaza | 1 Ma Sik Road, Fanling, NT | Large podium mall (four 29-storey residential towers above) | 86%, then 98%, then 94% | Largest Fanling estate of the past decade per company profile |
| Tai Hung Fai (Tsuen Wan) Centre, Portion A G/F | 55 Chung On Street, Tsuen Wan | Street shops plus signage and LED advertising | Acquired 30 Sep 2025 for HKD 260M; about 12,700 sq ft GFA; 100% let | A financial institution was introduced as tenant in 2026 |
| TN Residence (The Symphonie) | 280 Tung Chau Street, Cheung Sha Wan | 262 residential units (about 100,698 sq ft GFA) leased whole as a youth hostel | Rent from Jun 2025, adjusted by hostel occupancy; car park opened Apr 2026 | Operated by Tung Wah Group of Hospitals under the government's youth hostel subsidy scheme; URA-related site |
| The Royale leftover stock (JV) | 8 Castle Peak Road – Castle Peak Bay, Tuen Mun | 33 unsold units (Jun 2026); 10 units, 106 car spaces and 18 motorcycle spaces on short-term leases | 1,748 units sold and delivered | 50/50 JV with the Empire Group |
Investment property carrying value: HKD 2,488.7M (Dec 2023), HKD 2,495.8M (Dec 2024), HKD 4,555.5M (Dec 2025), HKD 4,548.9M (Jun 2026). The FY2025 step-up reflects the Symphonie reclassification from inventory, the Tai Hung Fai acquisition and a HKD 50.3M revaluation gain.
Gross rental income: arcades about HKD 122M (FY2023), arcades about HKD 125M (FY2024), arcades plus shops plus hostel about HKD 147M (FY2025, +17%), and HKD 97M in H1 2026 (+60% YoY).
Property development
| Project | Status | Economics |
|---|---|---|
| The Royale (TMTL 547) | Completed; 1,748 units delivered | 50% JV. Profits recognised mainly in FY2022 (group profit HKD 1.3B); a one-off post-tax construction-cost adjustment boosted FY2025 JV share to HKD 174.6M |
| The Symphonie | Completed Nov 2023; converted to rental in 2025 | Reclassified from "completed properties held for sale" to investment property in FY2025 |
| Pipeline | No new development site disclosed | Management is "actively seeking" investment opportunities |
Ferry, shipyard and related operations
| Offering | Description | Target customer | Pricing model | Latest development |
|---|---|---|---|---|
| North Point–Kwun Tong dangerous-goods vehicular ferry | The only licensed service carrying fuel trucks and other dangerous-goods vehicles across Victoria Harbour; supplies oil products for Hong Kong Island and flammable gases for hospitals and institutions | Fuel and gas distributors | Regulated fares approved by the Transport Department | Fare rises in Jan 2024, 12 Apr 2025 and 27 Jun 2026 |
| Vehicular ferry service | The group remains the only company offering vehicular ferry services (2025 Results) | Commercial vehicles | Regulated | Classic Vehicular Ferry Cruise in Victoria Harbour on public holidays |
| Harbour Cruise – Bauhinia | Dining and themed harbour cruises from North Point | Locals, tourists, events | Ticketed plus F&B | Pet-friendly dining cruise added Jul 2026 |
| Hong Kong Shipyard | Tsing Yi North yard of about 200,000 sq ft; synchrolift, one of the largest in Hong Kong; transfer system that can dry-dock up to 10 vessels at once; repair, maintenance, shipbuilding and civil engineering | Local shipowners, government and commercial fleets | Job/project basis | Revenue −12% in FY2025; partial land-use conversion under study |
| The Pierside Run 2026 | Cross-segment event combining ferry journeys and healthcare | Public | Event-based | Launched 2026 |
| Bicycle parking at North Point East Pier | Partnership with a local bicycle company | Public | — | 2,025 |
Medical, healthcare and beauty services
| Brand / unit | Location | Services | Launch | KPIs |
|---|---|---|---|---|
| AMOUR Aesthetic (AMOUR medical aesthetic centre) | Mira Place, Tsim Sha Tsui (about 12,000 sq ft, since expanded) | Skin, body contouring, hair revitalisation under a "Scientific Aesthetics" philosophy; service pledges of no hard selling, genuine authorised products and a 10-day cooling-off period | 2H 2022 | FY2024 turnover HKD 32M (+138%); HKD 15M prepaid packages deferred at Dec 2024; HK Emerging Service Brand award Feb 2026 |
| Total HealthCare Health Centres | Mira Place (TST); Metro Harbour Plaza (Tai Kok Tsui); Tai Hung Fai Centre (Tsuen Wan, trial from Jan 2026) | Pain management, chiropractic, sports training, orthopaedic and post-surgical rehabilitation | 2023/24 onwards | Three centres at Jun 2026 |
| Alliance Medical Centre (formerly Total HealthCare Specialists Centre) | H Zentre, TST, plus a second service point at Mira Place in a dual-centre model | Cardiology, surgery, orthopaedics, plastic surgery, urology (rheumatology listed in FY2024) | 1H 2023 (JV); renamed Nov 2025 | Profitable per management |
| Physiotherapy centre | H Zentre, TST | Physiotherapy with a fitness-centre partner of more than 20 years' standing | Aug 2025 | — |
| Medical equipment leasing | — | Devices co-purchased with specialists and leased to hospitals and doctors | 2H 2024 | — |
Segment revenue: HKD 13.8M (FY2023), HKD 40.1M (FY2024), HKD 57.1M (FY2025), HKD 34.2M (H1 2026).
Securities investment
The group holds a listed securities portfolio, valued at HKD 160.9M within "other financial assets" at Dec 2025 and HKD 158.8M at Jun 2026. Some of it is classified as FVOCI (non-recycling) and some as FVPL. It contributed a profit of HKD 23.9M in FY2025 and a loss of HKD 2.6M in H1 2026, when FVPL marks fell by HKD 5.8M. Individual holdings are not disclosed in the announcements.
Financial Narrative
Sources: audited figures from the 2024 and 2025 Results Announcements for FY2023 to FY2025; FY2021 and FY2022 figures from S&P Global Market Intelligence (StockAnalysis.com) and ET Net, cross-checked against the FY2022 earnings release (Simply Wall St). Blank cells mean the figure was not available from verified sources.
Income statement
Notes:
-
FY2023 underlying profit of about HKD 144M is derived from the FY2024 disclosure that underlying profit of HKD 158M was "approximately 10%" higher.
-
FY2021 and FY2022 JV share uses the S&P "earnings from equity investments" line.
-
The FY2020 base was revenue HKD 208.3M and profit attributable HKD 26.6M (ET Net).
Margins and growth (%)
Underlying EBITDA (analyst-derived) = profit from operations − IP valuation gains + depreciation and amortisation. This gives HKD 151.6M (FY2023), HKD 152.3M (FY2024) and HKD 136.0M (FY2025). Note that it includes bank interest income, which runs through "other revenue" and "Others". Excluding interest income, core operating EBITDA would be about HKD 52M (FY2023), HKD 59M (FY2024) and HKD 72M (FY2025), which shows the improving operating core.
Revenue CAGR: FY2021–FY2025 (4 years) is 15.0%; FY2020–FY2025 (5 years) is 15.5%. Growth decelerated sharply to 1.0% in FY2025 and re-accelerated to 20.5% in H1 2026.
Balance sheet
H1 2026 update (30 Jun 2026): total assets HKD 7,713M; cash HKD 2,205M; investment properties HKD 4,549M; shareholders' funds HKD 7,351M (HKD 20.63 per share); net current assets HKD 2,221M; current ratio 9.4×.
Short- versus long-term debt split: there is no bank debt in any year. Lease liabilities split into current HKD 8.4M and non-current HKD 13.9M (FY2025).
Cash flow: notes and sources
Source: S&P Global Market Intelligence via StockAnalysis.com. These figures are S&P-standardised and may differ from the company's statutory cash-flow presentation, particularly in the classification of time deposits, which explains the large "net change in cash" swings against the stable cash balance. TTM to June 2026: OCF HKD 130.9M, FCF HKD 125.7M.
Ratios
ROIC: 2.37% TTM per S&P. Analyst view: ROIC is not very meaningful for a company where cash is about 29% of equity.
Net debt/EBITDA: not meaningful (net cash).
Interest coverage: profit from operations ÷ lease interest was about 658× (FY2023), 285× (FY2024) and 292× (FY2025). The only interest cost is on leases.
Cash conversion cycle: not meaningful for this business mix. Trade debtors are billed on 7 to 45-day terms, and trade payables were mostly due within one month (HKD 115.6M of HKD 116.6M at Dec 2025).
Commentary on trends, inflections and drivers
Revenue. Revenue rose from HKD 244M to HKD 427M between FY2021 and FY2025. Three contributors drove this:
-
the post-COVID recovery of ferry, shipyard and cruise activity (ferry segment revenue +8% in FY2024);
-
the build-out of the medical business from zero to HKD 57M;
-
incremental rent from Tai Hung Fai (from Q4 2025) and TN Residence (from June 2025).
FY2025's 1% growth masked a 12% fall in shipyard revenue. The company attributed this to fewer Hong Kong-registered ships, owners buying more basic maintenance, and owners shifting work to Mainland yards. The H1 2026 rebound of 20.5% is driven by rent: gross rental income rose 60%.
Profit. Reported profit is dominated by non-recurring items. FY2022's HKD 1.3B came from recognising The Royale JV profits. FY2025's HKD 335M included a one-off post-tax construction-cost adjustment in the same JV, which lifted the JV share to HKD 174.6M against HKD 41.0M in FY2024, plus HKD 50.3M of revaluation gains. Underlying profit (excluding revaluation) was HKD 158M in FY2024 and HKD 284M in FY2025; the FY2025 figure still includes the JV one-off. The cleanest recurring earnings base is probably about HKD 140–160M a year, consistent with H1 2026 underlying profit of HKD 73M. That base faces pressure from falling interest income: bank interest fell from HKD 99.1M (FY2023) to HKD 93.5M (FY2024) to HKD 64.3M (FY2025), and to HKD 29.4M in H1 2026 against HKD 40.0M a year earlier.
Cost base. Administrative expenses rose from HKD 75.0M (FY2023) to HKD 98.2M (FY2024) to HKD 114.6M (FY2025), mainly because of medical-segment staffing. Staff costs went from HKD 114.9M to HKD 140.7M to HKD 143.7M. The medical segment's losses narrowed from HKD 37.8M to HKD 27.6M to HKD 4.4M, and it reached a HKD 1.3M profit in H1 2026, so the cost build is now being absorbed.
Balance sheet. The defining FY2025 change was the shift from inventory to investment property: inventory fell from HKD 1,803M to HKD 75M, and investment property rose from HKD 2,496M to HKD 4,556M. This converted a trading asset into a recurring-income asset and raised the group's exposure to revaluation volatility. Cash has stayed at HKD 1.8–2.2B throughout, even after the HKD 356M special dividend in 2023.
Tax. The effective tax rate dropped to 1.7% in FY2025 because the JV share is post-tax. It normalised to 14.0% in H1 2026 (HKD 13.0M tax, including a HKD 9.9M deferred-tax charge).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment (HKD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Property development | 0 | 0 | 0 |
Property investment | 170.1 | 172.3 | 193.9 |
Ferry shipyard and related operations | 164.6 | 177.9 | 165.8 |
Medical healthcare and beauty services | 13.8 | 40.1 | 57.1 |
Securities investment | 6.5 | 11.8 | 9.4 |
Others (interest mgmt fees corporate) | 103.2 | 90.6 | 64.4 |
Total segment revenue | 458.3 | 492.7 | 490.5 |
Of which reported Revenue line | 374.6 | 422.9 | 427.3 |
Of which Other revenue | 83.7 | 69.8 | 63.3 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment YoY growth (%)
| Segment YoY growth (%) | FY2024 | FY2025 |
|---|---|---|
Property investment | 1.3 | 12.5 |
Ferry shipyard and related | 8.0 | -6.8 |
Medical healthcare and beauty | 191.0 | 42.3 |
Securities investment | 80.1 | -20.2 |
Others | -12.2 | -28.9 |
Segment share of total segment revenue (%)
| Segment share of total segment revenue (%) | FY2023 | FY2024 |
|---|---|---|
Property investment | 37.1 | 35.0 |
Ferry shipyard and related | 35.9 | 36.1 |
Medical healthcare and beauty | 3.0 | 8.1 |
Securities investment | 1.4 | 2.4 |
Others | 22.5 | 18.4 |
Revenue by Segment and Revenue by Segment (%)
| Segment result (HKD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Property development | -0.7 | -9.2 | -10.4 |
Property investment (incl. revaluation) | 123.7 | 76.5 | 119.8 |
of which valuation gains on IP | 42.3 | 2.0 | 50.3 |
Property investment ex-revaluation | 81.4 | 74.5 | 69.5 |
Ferry shipyard and related | -7.6 | -8.0 | -20.1 |
Medical healthcare and beauty | -37.8 | -27.6 | -4.4 |
Securities investment | -2.3 | 16.4 | 23.9 |
Others | 99.1 | 86.9 | 57.2 |
Profit from operations | 174.3 | 134.9 | 166.1 |
Share of associates and JVs | 32.6 | 41.9 | 175.1 |
Profit before taxation | 206.6 | 176.3 | 340.6 |
Segment margin (%)
| Segment margin (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Property investment incl. revaluation | 72.7 | 44.4 | 61.8 |
Property investment ex-revaluation | 47.8 | 43.2 | 35.8 |
Ferry shipyard and related | -4.6 | -4.5 | -12.1 |
Medical healthcare and beauty | -274.6 | -68.9 | -7.6 |
Revenue by Segment (Half-Yearly)
| Segment (HKD Mn) | H1 2025 revenue | H1 2026 revenue | YoY % | H1 2025 result | H1 2026 result |
|---|---|---|---|---|---|
Property development | 0 | 0 | — | -6.0 | -0.1 |
Property investment | 82.2 | 123.0 | 49.7 | 83.6 | 69.1 |
Ferry shipyard and related | 73.9 | 84.2 | 14.0 | -12.5 | -9.1 |
Medical healthcare and beauty | 25.5 | 34.2 | 34.2 | -3.8 | 1.3 |
Securities investment | 5.7 | 4.4 | -23.2 | 15.4 | -2.6 |
Others | 40.1 | 30.1 | -24.9 | 36.5 | 26.4 |
Total | 227.3 | 275.9 | 21.4 | 113.1 | 85.1 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 244.2 | 280.6 | 374.6 | 422.9 | 427.3 |
Direct costs (HKD Mn) | 164.6 | 179.8 | 234.1 | 258.8 | 264.2 |
Gross profit (HKD Mn) | 79.6 | 100.9 | 140.5 | 164.1 | 163.1 |
Valuation gains on investment properties (HKD Mn) | 75.6 | 20.4 | 42.3 | 2.0 | 50.3 |
Profit from operations (HKD Mn) | — | — | 174.3 | 134.9 | 166.1 |
Share of JVs and associates (HKD Mn) | -31.2 | 1,180.0 | 32.6 | 41.9 | 175.1 |
Profit before tax (HKD Mn) | 138.6 | 1,355.9 | 206.6 | 176.3 | 340.6 |
Taxation (HKD Mn) | — | — | 20.8 | 15.9 | 5.9 |
Profit for the year (HKD Mn) | — | — | 185.9 | 160.4 | 334.7 |
Profit attributable to shareholders (HKD Mn) | 118.2 | 1,299.1 | 190.4 | 163.9 | 335.4 |
Underlying profit (HKD Mn) | — | — | 144 | 158 | 284 |
EPS basic and diluted (HKD) | 0.33 | 3.65 | 0.53 | 0.46 | 0.94 |
DPS ordinary (HKD) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
DPS special (HKD) | 0 | 1.00 | 0 | 0 | 0 |
DPS total (HKD) | 0.25 | 1.25 | 0.25 | 0.25 | 0.25 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue growth (%) | 17.3 | 14.9 | 33.5 | 12.9 | 1.0 |
Gross margin (%) | 32.6 | 35.9 | 37.5 | 38.8 | 38.2 |
Operating margin, profit from ops ÷ revenue (%) | — | — | 46.5 | 31.9 | 38.9 |
Underlying EBITDA margin (%) | — | — | 40.5 | 36.0 | 31.8 |
Net margin, attributable ÷ revenue (%) | 48.4 | 462.9 | 50.8 | 38.7 | 78.5 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 6,269 | 7,535 | 7,289 | 7,373 | 7,652 |
Cash and bank balances (HKD Mn) | 1,683 | 1,973 | 1,825 | 1,877 | 2,111 |
Investment properties (HKD Mn) | — | — | 2,489 | 2,496 | 4,556 |
Inventories, properties held for sale (HKD Mn) | 1,340 | 1,691 | 1,802 | 1,803 | 75 |
Interest in joint ventures (HKD Mn) | — | — | 700 | 691 | 389 |
Other financial assets (HKD Mn) | — | — | 107 | 133 | 161 |
Bank borrowings (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Lease liabilities total (HKD Mn) | 4.2 | 17.6 | 9.8 | 8.0 | 22.3 |
Net cash (HKD Mn) | 1,679 | 1,954 | 1,816 | 1,869 | 2,089 |
Shareholders funds (HKD Mn) | 6,005 | 7,218 | 6,971 | 7,063 | 7,320 |
Book value per share (HKD) | 16.85 | 20.26 | 19.57 | 19.82 | 20.55 |
Goodwill and intangibles (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Working capital (HKD Mn) | 2,993 | 3,676 | 3,551 | 3,639 | 2,157 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (HKD Mn) | 25.2 | -282.1 | 24.6 | 5.0 | 69.9 |
Capex, PP&E (HKD Mn) | 7.7 | 24.3 | 4.1 | 6.1 | 7.2 |
Investment property purchases (HKD Mn) | 9.4 | 63.9 | 105.3 | 5.1 | 281.8 |
Free cash flow, OCF − PP&E capex (HKD Mn) | 17.5 | -306.4 | 20.5 | -1.1 | 62.7 |
Dividends paid (HKD Mn) | 89.1 | 89.1 | 445.3 | 89.1 | 89.1 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Net change in cash, per S&P (HKD Mn) | 678.1 | -938.1 | -49.9 | 394.3 | -363.9 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE, attributable profit ÷ year-end equity (%) | 2.0 | 18.0 | 2.7 | 2.3 | 4.6 |
ROA, attributable profit ÷ total assets (%) | 1.9 | 17.2 | 2.6 | 2.2 | 4.4 |
Current ratio (x) | 17.2 | 16.9 | 15.8 | 17.0 | 10.2 |
Debt to equity, bank debt (x) | 0 | 0 | 0 | 0 | 0 |
Asset turnover, revenue ÷ total assets (x) | 0.039 | 0.037 | 0.051 | 0.057 | 0.056 |
Dividend payout, DPS ÷ EPS (%) | 76 | 34 | 47 | 54 | 27 |
Net cash as % of equity (%) | 28.0 | 27.1 | 26.1 | 26.5 | 28.5 |
Region revenue (HKD Mn)
| Region revenue (HKD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Hong Kong | 374.6 | 422.9 | 427.3 |
Rest of world | 0 | 0 | 0 |
District Details
| District | Segment exposure | Assets |
|---|---|---|
Tai Kok Tsui / Mong Kok West (Kowloon) | Property investment, medical | Metro6, Metro Harbour Plaza, Shining Heights, Total HealthCare |
Tsim Sha Tsui (Kowloon) | Medical | AMOUR (Mira Place), Total HealthCare (Mira Place), Alliance Medical Centre and physiotherapy (H Zentre) |
Cheung Sha Wan (Kowloon) | Property investment | TN Residence (The Symphonie) |
Kowloon East (Yau Tong area) | Property investment | The Spectacle arcade |
Fanling (New Territories North) | Property investment | Green Code Plaza |
Tsuen Wan (New Territories) | Property investment, medical | Tai Hung Fai Centre shops, Total HealthCare |
Tuen Mun (New Territories) | Development (JV) | The Royale |
Tsing Yi (New Territories) | Shipyard, HQ | Hong Kong Shipyard, head office |
North Point / Kwun Tong (harbour) | Ferry | Dangerous-goods ferry route; Bauhinia cruise pier |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Share price (HKD) | 4.70 | StockAnalysis.com (S&P) |
52-week change (%) | -3.29 | StockAnalysis.com |
50-day / 200-day moving average (HKD) | 4.85 / 4.96 | StockAnalysis.com |
Market cap (HKD Mn) | 1,674 | Computed |
Enterprise value (HKD Mn) | -522 | S&P (net cash exceeds market cap) |
P/E trailing TTM (x) | 5.71 | S&P (TTM EPS HKD 0.82) |
P/E on FY2025 EPS (x) | 5.0 | Computed |
P/B (x) | 0.23 | Computed on HKD 20.63 BVPS |
Price ÷ net cash per share (x) | 0.77 | Computed on HKD 6.14 net cash per share |
EV/EBITDA, EV/Sales | Not meaningful (negative EV) | — |
Dividend yield (%) | 5.3 | Computed on HKD 0.25 |
Beta, 5-year | 0.01 | S&P |
Average daily volume, 20-day (shares) | 138,327 | S&P |
Analyst coverage / consensus | None identified; no sell-side consensus | — |
Credit ratings (Moody's / S&P / Fitch) | Not rated | — |
Market Valuation and Share Price
| Metric | Mar 2025 | Apr 2025 | Aug 2025 | Oct 2026 |
|---|---|---|---|---|
Market cap (HKD Mn) | 1,470 | 1,496 | 1,710 | 1,674 |
Share price (HKD) | 4.13 | 4.20 | 4.80 | 4.70 |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Interim DPS (HKD) | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
Final DPS (HKD) | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
Special DPS (HKD) | 0 | 1.00 | 0 | 0 | 0 |
Total DPS (HKD) | 0.25 | 1.25 | 0.25 | 0.25 | 0.25 |
Total dividends declared (HKD Mn) | 89.1 | 445.3 | 89.1 | 89.1 | 89.1 |
Analyst Conclusions
Management guidance (2026 Interim)
Management gives no numerical guidance. It expects H2 2026 revenue to come primarily from property rentals and bank interest income, ferry losses to shrink after the fare rise effective 27 June 2026, and the medical ecosystem to keep expanding. It will keep the balance sheet liquid while looking for investments with reasonable returns. There is no sell-side consensus.
Analyst framework for FY2026
H1 2026 underlying profit was HKD 73M. H2 benefits from a full period of the fare increase and continued Tai Hung Fai and hostel rent, offset by lower interest income. FY2026 underlying profit therefore plausibly lands at about HKD 140–160M, roughly HKD 0.39–0.45 per share, with revaluations the swing factor. This is an analyst estimate, not company guidance.
Bull case
-
Asset backing. Shares at HKD 4.70 sit below net cash per share (HKD 6.14) and at 23% of book value (HKD 20.63). The market is effectively ascribing negative value to HKD 4.5B of investment property and to the operating businesses.
-
Earnings mix shift. Gross rent rose 60% in H1 2026, the medical segment turned profitable, and ferry losses are narrowing on fare increases. Core operating EBITDA excluding interest rose from about HKD 52M (FY2023) to about HKD 72M (FY2025).
-
Optionality. The HKD 2.2B cash pile, shipyard land conversion and remaining Royale stock offer re-rating catalysts, including a repeat of the FY2022 special dividend if any asset is realised.
Bear case
-
Value trap. ROE has stayed below 5% outside one-off years. With no buybacks and a flat dividend, controlling-shareholder alignment with minority holders is untested, and the discount has persisted.
-
Structural declines. Interest income is falling with rates, fuel-truck demand will erode with EV adoption, the shipyard is losing work to the Mainland, and Shining Heights occupancy has slid to 70%.
-
Reported profit volatility. Reported profit depends on revaluations and JV one-offs, so headline EPS is unreliable. H1 2026 profit attributable fell 34.5% despite revenue growth of 20.5%.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | Watch for |
|---|---|---|
| FY2026 annual results | March 2027 | Underlying profit, year-end revaluation, final and possibly special dividend |
| Ferry fare impact | H2 2026 results | Segment loss trend |
| Board of Review tax decision | Unknown | Tax liability quantum |
| Shipyard land-use study | Unknown | Planning application or rezoning |
| New acquisitions | Ongoing | Deployment of cash and yield achieved |
| Shining Heights re-tenanting | Ongoing | Occupancy recovery from 70% |
| Royale unsold units (33) | Ongoing | Sales or leasing |
| HIBOR path | Ongoing | Interest income run-rate |
| Medical segment profitability | FY2026 | Sustained positive margin |
| Capital return policy | AGM May 2027 | Buyback mandate or special dividend |
Concluding analyst verdict
Hong Kong Ferry (Holdings) is no longer a ferry company in any economic sense. It is a debt-free Hong Kong property and cash holding company with a regulated ferry niche and a nascent premium healthcare business attached. Its balance sheet is exceptional for its size. At 30 June 2026, shareholders' funds were HKD 7.35 billion, cash HKD 2.2 billion and investment properties HKD 4.55 billion, against a market capitalisation of about HKD 1.67 billion. Few Hong Kong-listed companies trade below net cash while also owning fully let community retail assets.
The past two years show real operating progress. Converting The Symphonie into the TN Residence youth hostel and buying the Tai Hung Fai shops have lifted recurring rent sharply. The medical business has moved from heavy losses to break-even, and the ferry is recovering costs through three fare increases in 30 months. Against this, interest income is in decline, ferry and shipyard volumes face structural erosion, and reported profit swings with revaluations and JV adjustments. The truer earnings base is about HKD 140–160 million a year of underlying profit, which still implies only about 2% on book equity.
The investment debate therefore turns on capital allocation rather than operations. The persistent discount reflects minority investors' doubt that the controlling shareholder will release value through buybacks, larger distributions or asset realisations. The flat HKD 0.25 dividend, now paid for at least five consecutive years, and the absence of any buyback mandate reinforce that doubt. The FY2022 HKD 1.00 special dividend shows the company will return capital after large realisations, but only episodically.
Verdict: this is a deep-value, low-volatility holding (beta about 0) offering a secure dividend yield of about 5.3% and substantial downside protection. Upside depends on catalysts outside minority investors' control: shipyard land conversion, deployment of the cash pile at attractive yields, or a special distribution. Rating stance: Accumulate for value, low conviction on timing.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Category | Notes |
|---|---|---|---|
Dr. Lam Ko Yin, Colin | Chairman | Executive Director | Long-serving Chairman; senior Henderson Land group executive. |
Mr. Li Ning | Director (co-signs results announcements) | Executive Director | Disclosed in 2016 as deemed interested in the Henderson-held block (Note 4 of the substantial shareholders table) |
Mr. Lee Gabriel | Group General Manager | Executive Director | Public face of results ("General Manager" in press releases); ED by March 2024 (not on the March 2022 board list) |
Mr. Au Siu Kee, Alexander | Director | Non-executive Director | On the board since at least 2022 |
Mr. Ho Hau Chong, Norman | Director | Independent Non-executive | On the board since at least 2022 |
Ms. Wong Yu Pok, Marina | Director | Independent Non-executive | Sole female director |
Mr. Wu King Cheong | Director | Independent Non-executive | On the board since at least 2022 |
Mr. Chan Wai Yan, Ronald | Director | Independent Non-executive | Joined between March 2022 and March 2024 |
Board & Management Changes
| Date | Change |
|---|---|
Between Mar 2022 and Mar 2024 | Mr. Lee Gabriel appointed Executive Director; Mr. Chan Wai Yan, Ronald appointed INED |
8 Dec 2023 | Mr. Chow Tung Ming appointed Company Secretary and authorised representative, succeeding Mr. Yuen Wai Kuen (retired) |
17 Mar 2025 | Death of Dr. Lee Shau Kee (director 1981–2020) |
Between Mar 2025 and Aug 2026 | Mr. |
Major Shareholders
| Holder | Shares | % | As at | Source |
|---|---|---|---|---|
Henderson Land Development Co. Ltd (through Pataca Enterprises, via Wiselin Investment 48,817,090; Graf Investment 23,400,000; Mount Sherpa 23,400,000; Paillard Investment 23,400,000) | 119,017,090 | 33.41 | 31 Dec 2016 (latest verified) | Annual Report 2016 |
Henderson Development Ltd; Hopkins, Rimmer and Riddick (Cayman) trusts | Same block (deemed) | 33.41 | 2,016 | Annual Report 2016 |
Free float (S&P estimate) | 231.03M | 64.8 | Oct 2026 | StockAnalysis.com |
Institutional ownership (S&P estimate) | — | 1.25 | Oct 2026 | StockAnalysis.com |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Positioning against HKF |
|---|---|---|
Ferry (harbour/outlying) | Star Ferry (Wharf group, private) | Passenger cross-harbour icon; no dangerous-goods service |
Ferry | Sun Ferry (formerly New World First Ferry) | Took over HYF's franchised routes in 2000; passenger focus |
Ferry | Hong Kong & Kowloon Ferry (HKKF) | Outlying-island passenger routes |
Ferry / marine leisure | Shun Tak Holdings (0242.HK; TurboJET JV) | Cross-boundary ferries plus property; larger and more diversified |
Harbour cruises | Water Taxi / Aqua Luna and other private cruise operators | Leisure harbour-cruise competitors to Bauhinia |
Shipyard | Mainland GBA shipyards; local private yards (e.g. Cheoy Lee, Yiu Lian Dockyards) | Lower-cost Mainland yards are taking maintenance work, per HKF |
Community retail landlord | Link REIT (0823.HK) | Dominant owner of community malls; scale advantage |
Community retail landlord | Henderson Land (0012.HK), Sun Hung Kai Properties (0016.HK), New World / K11 | Large developer-landlords near HKF's malls |
Diversified small-cap property | Kowloon Development (0034), Chinese Estates (0127), Wang On Properties (1243), CSI Properties (0497) | Comparable small/mid-cap HK property names |
Medical aesthetics | Perfect Medical Health Management (1830.HK); Mainland GBA aesthetics clinics | Larger listed aesthetics chain; GBA price competition |
Medical / specialist | UMP Healthcare (0722.HK); private hospital outpatient services (e.g. HK Sanatorium, Gleneagles) | Specialist networks; hospitals cutting outpatient fees |
Pain / chiropractic | Independent chiropractic and physiotherapy chains | Fragmented market |
Peer Comparison FY2025
| Metric | HKF (FY2025) | Link REIT |
|---|---|---|
Revenue (HKD Mn) | 427 | — |
Revenue growth (%) | 1.0 | — |
Gross margin (%) | 38.2 | — |
R&D intensity (%) | 0 | — |
Balance sheet | Net cash about HKD 2.1B | Leveraged REIT |
Overlap with HKF | — | Community retail |
“—” = not publicly disclosed.
Recent Developments
Entries from just before the window are included for context.
There were no layoffs, guidance revisions, regulatory sanctions or new litigation in the window, other than the ongoing tax appeal.



